<SEC-DOCUMENT>0001213900-25-007997.txt : 20250129
<SEC-HEADER>0001213900-25-007997.hdr.sgml : 20250129
<ACCEPTANCE-DATETIME>20250129192910
ACCESSION NUMBER:		0001213900-25-007997
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250129
DATE AS OF CHANGE:		20250129

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cadrenal Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001937993
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880860746
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94027
		FILM NUMBER:		25570680

	BUSINESS ADDRESS:	
		STREET 1:		822 A1A NORTH
		STREET 2:		SUITE 306
		CITY:			PONTE VEDRA
		STATE:			FL
		ZIP:			32082
		BUSINESS PHONE:		904-300-0701

	MAIL ADDRESS:	
		STREET 1:		822 A1A NORTH
		STREET 2:		SUITE 306
		CITY:			PONTE VEDRA
		STATE:			FL
		ZIP:			32082

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pham Quang X
		CENTRAL INDEX KEY:			0001405290
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	MAIL ADDRESS:	
		STREET 1:		89 MELROSE DRIVE
		CITY:			MISSION VIEJO
		STATE:			CA
		ZIP:			92692
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Pham Quang X -->
          <cik>0001405290</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <dateOfEvent>01/23/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001937993</issuerCIK>
        <issuerCUSIP>127636207</issuerCUSIP>
        <issuerName>Cadrenal Therapeutics, Inc.</issuerName>
        <address>
          <com:street1>822 A1A North</com:street1>
          <com:street2>Suite 306</com:street2>
          <com:city>Ponte Vedra</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>32082</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Quang Pham</personName>
          <personPhoneNum>(904) 300-0701</personPhoneNum>
          <personAddress>
            <com:street1>c/o Cadrenal Therapeutics, Inc.</com:street1>
            <com:street2>822 A1A North, Suite 306</com:street2>
            <com:city>Ponte Vedra</com:city>
            <com:stateOrCountry>FL</com:stateOrCountry>
            <com:zipCode>32082</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001405290</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Quang X. Pham</reportingPersonName>
        <fundType>PF</fundType>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>221042.00</soleVotingPower>
        <sharedVotingPower>200000.00</sharedVotingPower>
        <soleDispositivePower>221042.00</soleDispositivePower>
        <sharedDispositivePower>200000.00</sharedDispositivePower>
        <aggregateAmountOwned>421042.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>23.6</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>Rows 7 and 9 include: (i) 218,333 shares of Common Stock owned by the Reporting Person; and (ii) 2,709 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person which are currently exercisable or may be exercised within 60 days of January 23, 2025. Does not include 72,291 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person that are not exercisable within 60 days of January 23, 2025. Rows 8 and 10 include 200,000 shares of Common Stock owned by The PVBQ Living Trust (the "Trust"). The beneficiary of the Trust is Mr. Pham's child and Mr. Pham is the trustee of the Trust and has sole voting and dispositive power with respect to the shares owned by the Trust. Rows 11 and 13 include: (i) 218,333 shares of Common Stock owned by the Reporting Person; (ii) 2,709 shares of Common Stock issuable upon the exercise of stock options held by the Reporting Person which are currently exercisable or may be exercised within 60 days of January 23, 2025; and (iii) 200,000 shares of Common Stock owned by the Trust. Percentage is based on 1,782,486 shares of Common Stock of the Issuer outstanding as of January 23, 2025.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001947432</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>The PVBQ Living Trust</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>FL</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>200000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>200000.00</sharedDispositivePower>
        <aggregateAmountOwned>200000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>11.2</percentOfClass>
        <typeOfReportingPerson>OO</typeOfReportingPerson>
        <commentContent>Rows 8, 10, 11 and 13 include 200,000 shares of Common Stock owned by The PVBQ Living Trust (the "Trust"). The beneficiary of the Trust is Mr. Pham's child and Mr. Pham is the trustee of the Trust and has sole voting and dispositive power with respect to the shares owned by the Trust. Percentage is based on 1,782,486 shares of Common Stock of the Issuer outstanding as of January 23, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.001 par value per share</securityTitle>
        <issuerName>Cadrenal Therapeutics, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>822 A1A North</com:street1>
          <com:street2>Suite 306</com:street2>
          <com:city>Ponte Vedra</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>32082</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>Quang X. Pham (sometimes referred to as the "Reporting Person") and The PVBQ Living Trust (sometimes referred to as the "Trust"). The beneficiary of the Trust is Mr. Pham's child and Mr. Pham is the trustee of the Trust, with sole voting and dispositive power with respect to the shares owned by the Trust.</filingPersonName>
        <principalBusinessAddress>The address for the principal business office of the Reporting Person and the Trust is: c/o Cadrenal Therapeutics, Inc. 822 A1A North, Suite 306 Ponte Vedra, Florida 32082</principalBusinessAddress>
        <principalJob>The Reporting Person is the Chairman of the Board of Directors and Chief Executive Officer of the Issuer.</principalJob>
        <hasBeenConvicted>During the past five years, neither the Reporting Person nor the Trust have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the past five years, neither the Reporting Person nor the Trust have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, which resulted in the Reporting Person or the Trust, as applicable, being subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>The Reporting Person is a citizen of the United States. The Trust was formed under the laws of the State of Florida for estate planning purposes.</citizenship>
      </item2>
      <item3>
        <fundsSource>The shares of Common Stock reported herein as beneficially owned by the Reporting Person were: (i) purchased with personal funds; or (ii) granted as compensation for the Reporting Person's services as an employee of the Issuer. The shares of Common Stock reported herein as beneficially owned by the Trust were acquired from the Reporting Person as a gift for no consideration.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The shares of Common Stock reported herein as beneficially owned by the Reporting Person and the Trust were acquired by the Reporting Person and the Trust, as applicable, for investment purposes.

As Chief Executive Officer of the Issuer and Chairman of its Board of Directors, the Reporting Person will regularly explore potential actions and transactions that may be advantageous to the Issuer, including possible mergers, acquisitions, reorganizations or other material changes in the business, corporate structure, management, policies, governing instruments, securities or regulatory or reporting obligations of the Issuer.

Except as discussed above in the Reporting Person's capacity as Chief Executive Officer and Chairman of the Board of the Issuer, the Reporting Person does not have any present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

The Reporting Person may, from time to time, acquire additional shares of Common Stock (1) by the exercise or vesting of currently held options (See Annex A), (2) by the grant of additional options to the Reporting Person by the Issuer, (3) from time to time in open market purchases for investment purposes if market conditions are favorable, or (4) any combination of the foregoing. The Trust may, from time to time, acquire additional shares of Common Stock as a gift for no consideration.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>The responses set forth in rows 11 through 13 and the related "Comments for Type of Reporting Person" on the cover pages to this Schedule 13D are incorporated by reference into this Item 5.</percentageOfClassSecurities>
        <numberOfShares>The responses set forth in rows 7 through 10 and the related "Comments for Type of Reporting Person" on the cover pages to this Schedule 13D are incorporated by reference into this Item 5.</numberOfShares>
        <transactionDesc>Except as set forth in Annex A, the Reporting Person has not effected any transactions in securities of the Issuer during the past 60 days. The Trust has not effected any transactions in securities of the Issuer during the past 60 days.</transactionDesc>
        <listOfShareholders>As discussed in rows 7 through 10 and the related "Comments for Type of Reporting Person" on the cover pages to this Schedule 13D, certain shares of Common Stock that the Reporting Person may be deemed to own beneficially are held by or on behalf of persons other than the Reporting Person, which other persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Other than as indicated in this statement, the Reporting Person and the Trust are not a party to any contract, arrangement, understanding, or relationship (legal or otherwise) with any person with respect to any securities of the Issuer, including but not limited to, the transfer or voting of any of the Issuer's securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 1 - Annex A
Exhibit 2 - Joint Filing Agreement</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Quang X. Pham</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Quang X. Pham</signature>
          <title>Quang X. Pham</title>
          <date>01/29/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>The PVBQ Living Trust</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Quang X. Pham</signature>
          <title>Quang X. Pham, Trustee</title>
          <date>01/29/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea022913001ex99-1_cardenal.htm
<DESCRIPTION>ANNEX A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0">&nbsp;<B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annex A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Transactions in the Shares of Common Stock
by the Reporting Person Within the Last Sixty Days</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Vesting of Stock Options</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the last 60 days, a stock option to purchase 2,500 shares of
the Issuer&rsquo;s Common Stock previously granted under the Issuer&rsquo;s equity plans vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Reporting Person currently has the following outstanding restricted
stock units and options pursuant to the Issuer&rsquo;s equity plans:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Date of<BR> Grant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type of<BR> Award</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> shares<BR> Underlying<BR> Award</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<BR> Exercise<BR> Price Per<BR> Share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Vesting<BR> Schedule</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration<BR> Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Portion Vested at 01/23/2025<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 15%; vertical-align: top">01/18/2024</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 15%; text-align: left">Stock Option <BR>(Nonstatutory)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; width: 9%; text-align: right">10,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: left">$</TD><TD STYLE="vertical-align: top; width: 9%; text-align: right">14.10</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: left">Vesting &frac14; on 02/01/2025 and thereafter pro rata on a monthly basis over 3 years.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 11%; vertical-align: top">01/17/2034</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; vertical-align: top">01/23/2025</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Stock Option <BR>(Nonstatutory)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; text-align: right">65,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">$</TD><TD STYLE="vertical-align: top; text-align: right">19.79</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Vesting &frac14; on 02/01/2026 and thereafter pro rata on a monthly basis over 3 years</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">01/22/2035</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">The vesting of the unvested stock options described in this
table will increase the Reporting Person&rsquo;s beneficial ownership of Common Stock.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>3
<FILENAME>ea022913001ex-2_cardenal.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U STYLE="text-decoration: none">Exhibit 99.2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>JOINT FILING AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">JOINT FILING AGREEMENT, dated as of January 29, 2025, among Quang Pham
and The PVBQ Living Trust (collectively, the &ldquo;Reporting Persons&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">WHEREAS, pursuant to Rule 13d-1(k) under the Securities Exchange Act
of 1934, as amended (the &ldquo;Exchange Act&rdquo;), the parties hereto desire to satisfy any filing obligation under Section&nbsp;13(d)
of the Exchange Act by a single joint filing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOW, THEREFORE, in consideration of the premises and the mutual covenants
herein contained, the Reporting Persons hereby agree and represent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule 13D with respect to the Common Stock, par value $0.001 per share, of Cadrenal Therapeutics, Inc. (to which this Joint Filing Agreement is an exhibit) is filed on behalf of each of the Reporting Persons.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="vertical-align: top; width: 94%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the Reporting Persons is responsible for the timely filing of Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such Person contained therein, provided that each such Person is not responsible for the completeness or accuracy of the information concerning any of the other Reporting Persons, unless such Person knows or has reason to believe that such information is inaccurate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the undersigned have caused this Joint Filing Agreement
to be duly executed and delivered as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Quang Pham</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quang Pham</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE PVBQ LIVING TRUST</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Quang Pham</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quang Pham</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
